GLP-1 Weight-Loss Drugs May Shield Heart Microvessels After Heart Attacks
A Bristol/UCL study suggests GLP-1 weight-loss meds like semaglutide and liraglutide may protect heart tissue after a heart attack by relaxing pericytes and widening microvessels to prevent ‘no-reflow’—a finding from animal studies that hints at repurposing these drugs for post-infarct cardioprotection, though human trials are needed.
